99 related articles for article (PubMed ID: 1542920)
21. Platelet concentrates prepared and stored under currently optimal conditions: minor impact on platelet adhesive and cohesive functions after storage.
Lozano M; Estebanell E; Cid J; Diaz-Ricart M; Mazzara R; Ordinas A; Escolar G
Transfusion; 1999 Sep; 39(9):951-9. PubMed ID: 10533821
[TBL] [Abstract][Full Text] [Related]
22. [Effect of leukocyte contamination on storage of platelet concentrates from buffy coats].
Klüter H; Klinger M; Bauhaus M; Kirchner H
Beitr Infusionsther Transfusionsmed; 1994; 32():61-5. PubMed ID: 9480159
[TBL] [Abstract][Full Text] [Related]
23. Leukoreduced buffy coat-derived platelet concentrates photochemically treated with amotosalen HCl and ultraviolet A light stored up to 7 days: assessment of hemostatic function under flow conditions.
Lozano M; Galan A; Mazzara R; Corash L; Escolar G
Transfusion; 2007 Apr; 47(4):666-71. PubMed ID: 17381625
[TBL] [Abstract][Full Text] [Related]
24. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
Albanyan AM; Harrison P; Murphy MF
Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
26. Platelet metabolism during storage of platelet concentrates at 22 degrees C.
Kilkson H; Holme S; Murphy S
Blood; 1984 Aug; 64(2):406-14. PubMed ID: 6430365
[TBL] [Abstract][Full Text] [Related]
27. Growth factor release during preparation and storage of platelet concentrates.
Ledent E; Wasteson A; Berlin G
Vox Sang; 1995; 68(4):205-9. PubMed ID: 7660637
[TBL] [Abstract][Full Text] [Related]
28. Cytokines in platelet concentrates prepared from pooled buffy coats.
Klüter H; Müller-Steinhardt M; Danzer S; Wilhelm D; Kirchner H
Vox Sang; 1995; 69(1):38-43. PubMed ID: 7483490
[TBL] [Abstract][Full Text] [Related]
29. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
Singh S; Shams Hakimi C; Jeppsson A; Hesse C
Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
[TBL] [Abstract][Full Text] [Related]
30. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system.
Plaza EM; Céspedes P; Fernández H; Sánchez-Guiu MI; Egea JM; Vicente V; Lozano ML; Rivera J
Vox Sang; 2014 Jan; 106(1):38-44. PubMed ID: 23888911
[TBL] [Abstract][Full Text] [Related]
31. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
Ali SF
Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
[TBL] [Abstract][Full Text] [Related]
32. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
[TBL] [Abstract][Full Text] [Related]
33. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
34. Improved in-vitro quality of platelet concentrates stored in a dextrose-free synthetic medium.
Farrugia A; Douglas S; Williams S; Kellner S; Amerena L; James J
Transfus Med; 1991 Mar; 1(1):31-8. PubMed ID: 9259824
[TBL] [Abstract][Full Text] [Related]
35. Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system.
Kretschmer V; Biermann E; Loh H
Beitr Infusionsther; 1990; 26():65-70. PubMed ID: 1703903
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats.
van Rhenen DJ; Vermeij H; Kappers-Klunne M; Payrat JM
Transfusion; 1995 Jan; 35(1):50-3. PubMed ID: 7998070
[TBL] [Abstract][Full Text] [Related]
37. Are all leucodepleted platelet concentrates equivalent? Comparison of Cobe LRS Turbo, Haemonetics MCS+ LD, and filtered pooled buffy-coat-derived platelets.
Krailadsiri P; Seghatchian J
Vox Sang; 2000; 78(3):171-5. PubMed ID: 10838518
[TBL] [Abstract][Full Text] [Related]
38. Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations.
Krailadsiri P; Seghatchian J; Williamson LM
Transfusion; 2001 Feb; 41(2):243-50. PubMed ID: 11239230
[TBL] [Abstract][Full Text] [Related]
39. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
[TBL] [Abstract][Full Text] [Related]
40. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
